| Serial Number | 97280562 |
| Word Mark | OPZONVA |
| Filing Date | Wednesday, February 23, 2022 |
| Status | 732 - THIRD EXTENSION - GRANTED |
| Status Date | Thursday, June 6, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, November 1, 2022 |
| Goods and Services | Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin), musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, March 1, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | TEVA PHARMACEUTICALS USA, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Parsippany, NJ 07054 |
| Party Name | TEVA PHARMACEUTICALS USA, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Parsippany, NJ 07054 |
| Event Date | Event Description |
| Saturday, February 26, 2022 | NEW APPLICATION ENTERED |
| Tuesday, March 1, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, July 7, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, July 7, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, July 7, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, September 20, 2022 | ASSIGNED TO EXAMINER |
| Wednesday, September 28, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, October 12, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, November 1, 2022 | PUBLISHED FOR OPPOSITION |
| Tuesday, November 1, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, December 27, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, February 2, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, February 2, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, February 2, 2023 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Thursday, February 2, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, June 21, 2023 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, June 21, 2023 | SOU EXTENSION 1 FILED |
| Wednesday, June 21, 2023 | SOU EXTENSION 1 GRANTED |
| Friday, June 23, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, December 21, 2023 | SOU TEAS EXTENSION RECEIVED |
| Thursday, December 21, 2023 | SOU EXTENSION 2 FILED |
| Thursday, December 21, 2023 | SOU EXTENSION 2 GRANTED |
| Saturday, December 23, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, June 6, 2024 | SOU TEAS EXTENSION RECEIVED |
| Thursday, June 6, 2024 | SOU EXTENSION 3 FILED |
| Thursday, June 6, 2024 | SOU EXTENSION 3 GRANTED |
| Thursday, June 13, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |